These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18179664)

  • 1. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.
    Levy AR; Kowdley KV; Iloeje U; Tafesse E; Mukherjee J; Gish R; Bzowej N; Briggs AH
    Value Health; 2008; 11(3):527-38. PubMed ID: 18179664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health state utilities and quality of life in patients with hepatitis B.
    Woo G; Tomlinson G; Yim C; Lilly L; Therapondos G; Wong DK; Ungar WJ; Einarson TR; Sherman M; Heathcote JE; Krahn M
    Can J Gastroenterol; 2012 Jul; 26(7):445-51. PubMed ID: 22803020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life (HRQoL) and health state utilities with chronic hepatitis-B (CHB): A population-based survey in Vietnam.
    Tran QV; Vo TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S80-S86. PubMed ID: 31369538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-state utilities and quality of life in hepatitis C patients.
    Chong CA; Gulamhussein A; Heathcote EJ; Lilly L; Sherman M; Naglie G; Krahn M
    Am J Gastroenterol; 2003 Mar; 98(3):630-8. PubMed ID: 12650799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study.
    Zhang M; Li Y; Fan Z; Shen D; Huang X; Yu Q; Liu M; Ren F; Wang X; Dai L; Wang P; Ye H; Shi J; Yang X; Zhang S; Zhang J
    BMJ Open; 2021 Sep; 11(9):e047475. PubMed ID: 34526336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.
    Hsu PC; Federico CA; Krajden M; Yoshida EM; Bremner KE; Anderson FH; Weiss AA; Krahn MD
    J Gastroenterol Hepatol; 2012 Jan; 27(1):149-57. PubMed ID: 21679248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of utilities for chronic hepatitis C from SF-36 scores.
    Thein HH; Krahn M; Kaldor JM; Dore GJ
    Am J Gastroenterol; 2005 Mar; 100(3):643-51. PubMed ID: 15743364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis.
    Wu B; Li T; Chen H; Shen J
    Value Health; 2010 Aug; 13(5):592-600. PubMed ID: 20561341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life of Southern Chinese with chronic hepatitis B infection.
    Lam ET; Lam CL; Lai CL; Yuen MF; Fong DY; So TM
    Health Qual Life Outcomes; 2009 Jun; 7():52. PubMed ID: 19500349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-state utilities in liver disease: a systematic review.
    McLernon DJ; Dillon J; Donnan PT
    Med Decis Making; 2008; 28(4):582-92. PubMed ID: 18424560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    Liu Y; Zhang S; Zhao Y; Du J; Jin G; Shao S; Lu X
    PLoS One; 2016; 11(9):e0162763. PubMed ID: 27631983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of rheumatoid arthritis on the burden of disease in urban China.
    Langley PC; Mu R; Wu M; Dong P; Tang B
    J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China.
    Huang J; Guan ML; Balch J; Wu E; Rao H; Lin A; Wei L; Lok AS
    Liver Int; 2016 Nov; 36(11):1595-1603. PubMed ID: 27206379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cirrhosis affect quality of life in hepatitis C virus-infected patients?
    Hsu PC; Krajden M; Yoshida EM; Anderson FH; Tomlinson GA; Krahn MD
    Liver Int; 2009 Mar; 29(3):449-58. PubMed ID: 19267865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.
    Yuan Y; Iloeje U; Li H; Hay J; Yao GB
    Value Health; 2008 Mar; 11 Suppl 1():S11-22. PubMed ID: 18387054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.
    Lee KK; Wu DB; Chow PY; Lee VW; Li H
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1167-74. PubMed ID: 22141402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey.
    Karacaer Z; Cakir B; Erdem H; Ugurlu K; Durmus G; Ince NK; Ozturk C; Hasbun R; Batirel A; Yilmaz EM; Bozkurt I; Sunbul M; Aynioglu A; Atilla A; Erbay A; Inci A; Kader C; Tigen ET; Karaahmetoglu G; Coskuner SA; Dik E; Tarakci H; Tosun S; Korkmaz F; Kolgelier S; Karadag FY; Erol S; Turker K; Necan C; Sahin AM; Ergen P; Iskender G; Korkmaz P; Eroglu EG; Durdu Y; Ulug M; Deniz SS; Koc F; Alpat SN; Oztoprak N; Evirgen O; Sozen H; Dogan M; Kaya S; Kaya S; Altindis M; Aslan E; Tekin R; Sezer BE; Ozdemir K; Ersoz G; Sahin A; Celik I; Aydin E; Bastug A; Harman R; Ozkaya HD; Parlak E; Yavuz I; Sacar S; Comoglu S; Yenilmez E; Sirmatel F; Balkan II; Alpay Y; Hatipoglu M; Denk A; Senol G; Bitirgen M; Geyik MF; Guner R; Kadanali A; Karakas A; Namiduru M; Udurgucu H; Boluktas RP; Karagoz E; Ormeci N
    Health Qual Life Outcomes; 2016 Nov; 14(1):153. PubMed ID: 27809934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
    Hu M; Chen W
    Value Health; 2009; 12 Suppl 3():S89-92. PubMed ID: 20586991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls.
    Zhuang G; Zhang M; Liu Y; Guo Y; Wu Q; Zhou K; Ji Z; Zhang X
    Health Qual Life Outcomes; 2014 Jun; 12():101. PubMed ID: 24928466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.